Ann-Kathrin Heilsberg
Papers
1
Total Citations
12
H-Index
1
About
Ann-Kathrin Heilsberg is a clinical researcher whose work sits at the intersection of urologic oncology and evidence-based surgical outcomes. Her primary research focuses on age-related disparities in prostate cancer treatment, with a particular emphasis on how radical prostatectomy affects patients across different life stages. Her most cited study, "Age-stratified outcomes after radical prostatectomy in a randomized setting (LAP-01): do younger patients have more to lose?" (2022, 12 citations), is notable for its dual analytical approach—combining cross-sectional and longitudinal perspectives to challenge conventional assumptions about surgical risk. This work, drawn from the first multicenter randomized trial of its kind, reveals that younger patients may face distinct functional and oncologic trade-offs, a finding with direct implications for shared decision-making in clinical practice. Heilsberg’s contributions are especially valuable for their methodological rigor and patient-centered framing, helping to refine risk stratification in prostate cancer care. Her research is steadily gaining traction among urologists and health services researchers, positioning her as an emerging voice in the push for more personalized, age-aware treatment protocols.
Research Focus
Key Achievements
Top Papers
- 1